Moderna CMO Jacqueline Miller to step down - Yahoo Finance

Moderna CMO Jacqueline Miller to step down  Yahoo Finance

Moderna offloads late-stage rare disease drug for $50M upfront - Fierce Biotech

Moderna offloads late-stage rare disease drug for $50M upfront  Fierce Biotech

David Berman to join Moderna executive team - The Pharma Letter

David Berman to join Moderna executive team  The Pharma Letter

Moderna Teams With Recordati on Rare Disease mRNA Therapy for up to $160M - BioSpace

Moderna Teams With Recordati on Rare Disease mRNA Therapy for up to $160M  BioSpace

Moderna holds a ‘garage sale’; Roche defends obesity drug data - BioPharma Dive

Moderna holds a ‘garage sale’; Roche defends obesity drug data  BioPharma Dive

Moderna announces departure of medical chief (MRNA:NASDAQ) - Seeking Alpha

Moderna announces departure of medical chief (MRNA:NASDAQ)  Seeking Alpha

Moderna's latest CMO steps down after barely a year - Fierce Biotech

Moderna's latest CMO steps down after barely a year  Fierce Biotech

Moderna CMO Jacqueline Miller to step down - Reuters

Moderna CMO Jacqueline Miller to step down  Reuters

Biopharma bites: Regeneron's 4Q results, Recordati's mRNA deal, plus new leadership at Moderna, N...

Biopharma bites: Regeneron's 4Q results, Recordati's mRNA deal, plus new leadership at Moderna, Novo Nordisk  FirstWord Pharma

Moderna and Recordati collaborate on rare disease mRNA therapy - European Pharmaceutical Review

Moderna and Recordati collaborate on rare disease mRNA therapy  European Pharmaceutical Review

Dr. David Berman to Join Moderna as Chief Development Officer - ACCESS Newswire

Dr. David Berman to Join Moderna as Chief Development Officer  ACCESS Newswire

Immunotherapy veteran David Berman to steer drug development at Moderna - Stock Titan

Immunotherapy veteran David Berman to steer drug development at Moderna  Stock Titan

Moderna: Analyzing The January Rally And The Road Ahead (Rating Upgrade) (NASDAQ:MRNA) - Seeking ...

Moderna: Analyzing The January Rally And The Road Ahead (Rating Upgrade) (NASDAQ:MRNA)  Seeking Alpha

Recordati inks deal for Moderna drug - The Pharma Letter

Recordati inks deal for Moderna drug  The Pharma Letter

Moderna chief: Company won’t invest in new late-stage vaccine trials - CIDRAP

Moderna chief: Company won’t invest in new late-stage vaccine trials  CIDRAP

Moderna licenses Phase 3 asset to Recordati; ProMIS’ private placement - Endpoints News

Moderna licenses Phase 3 asset to Recordati; ProMIS’ private placement  Endpoints News

Moderna stock price target lowered to $17 at Leerink on Recordati deal - Investing.com

Moderna stock price target lowered to $17 at Leerink on Recordati deal  Investing.com

Roche Makes Obesity Splash, Moderna Cans Vaccine Trials, Sarepta’s New Data, More - BioSpace

Roche Makes Obesity Splash, Moderna Cans Vaccine Trials, Sarepta’s New Data, More  BioSpace

Rare metabolic disease drug mRNA-3927 draws up to $160M Moderna-Recordati pact - Stock Titan

Rare metabolic disease drug mRNA-3927 draws up to $160M Moderna-Recordati pact  Stock Titan

Moderna (MRNA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

Moderna (MRNA) Stock Falls Amid Market Uptick: What Investors Need to Know  Yahoo Finance

Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? (MRNA) - Seek...

Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? (MRNA)  Seeking Alpha

Moderna, Inc. $MRNA Stock Holdings Reduced by Universal Beteiligungs und Servicegesellschaft mbH ...

Moderna, Inc. $MRNA Stock Holdings Reduced by Universal Beteiligungs und Servicegesellschaft mbH  MarketBeat

Moderna appoints David Berman as new chief development officer - Investing.com

Moderna appoints David Berman as new chief development officer  Investing.com

Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026 - Yahoo Finance

Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026  Yahoo Finance

Jim Cramer on Moderna: “We Have to Wait and See” - Yahoo Finance

Jim Cramer on Moderna: “We Have to Wait and See”  Yahoo Finance

Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials - Fierce...

Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials  Fierce Biotech

Moderna (MRNA) Announces Leadership Changes Amid Strategic Shift - GuruFocus

Moderna (MRNA) Announces Leadership Changes Amid Strategic Shift  GuruFocus

Moderna, Inc. Announces Executive and Committee Changes, Effective March 2, 2026 - marketscreener...

Moderna, Inc. Announces Executive and Committee Changes, Effective March 2, 2026  marketscreener.com

Moderna COVID vaccine 53% effective against adult hospitalization in 2024-25 season, data suggest...

Moderna COVID vaccine 53% effective against adult hospitalization in 2024-25 season, data suggest  CIDRAP

Moderna and Merck’s melanoma vaccine shows promising results - KTVB

Moderna and Merck’s melanoma vaccine shows promising results  KTVB

Moderna CMO Jacqueline Miller to step down - marketscreener.com

Moderna CMO Jacqueline Miller to step down  marketscreener.com

Moderna investors prepare for a phase 3 reveal | ApexOnco - Clinical Trials news and analysis - O...

Moderna investors prepare for a phase 3 reveal | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

Moderna Stock Soars. Why a Cancer Vaccine Study Has Sparked a Rally. - Barron's

Moderna Stock Soars. Why a Cancer Vaccine Study Has Sparked a Rally.  Barron's

Recordati partners with Moderna on rare disease treatment - Investing.com

Recordati partners with Moderna on rare disease treatment  Investing.com

CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate - CEPI

CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate  CEPI

Moderna curbing investments in vaccine trials due to US backlash, CEO tells Bloomberg TV - Reuters

Moderna curbing investments in vaccine trials due to US backlash, CEO tells Bloomberg TV  Reuters

Moderna partners with Recordati on rare disease therapy - Investing.com

Moderna partners with Recordati on rare disease therapy  Investing.com

Moderna does not ‘foresee investing’ in Phase III trials, says CEO - BioXconomy

Moderna does not ‘foresee investing’ in Phase III trials, says CEO  BioXconomy

Moderna CEO addresses company future in 2025 shareholder letter - BioProcess International

Moderna CEO addresses company future in 2025 shareholder letter  BioProcess International

Moderna Won’t Run Phase III Vaccine Trials as Skepticism Grows in US: Bloomberg - BioSpace

Moderna Won’t Run Phase III Vaccine Trials as Skepticism Grows in US: Bloomberg  BioSpace

Moderna-Merck & Co cancer vaccine with Keytruda shows late-stage promise - European Pharmaceutica...

Moderna-Merck & Co cancer vaccine with Keytruda shows late-stage promise  European Pharmaceutical Review

Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigationa...

Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)  ACCESS Newswire

Moderna, Merck Show Long-Term Survival for mRNA-Keytruda Combo - BioSpace

Moderna, Merck Show Long-Term Survival for mRNA-Keytruda Combo  BioSpace

Moderna cancer vaccine holds up; IO Biotech considers a sale - BioPharma Dive

Moderna cancer vaccine holds up; IO Biotech considers a sale  BioPharma Dive

Moderna expects $1.9 billion in sales, trims costs forecast for 2025 - Reuters

Moderna expects $1.9 billion in sales, trims costs forecast for 2025  Reuters

I Hope Moderna (MRNA) Posts Growth, Says Jim Cramer - Yahoo Finance

I Hope Moderna (MRNA) Posts Growth, Says Jim Cramer  Yahoo Finance

Assessing Moderna (MRNA) Valuation After Promising Melanoma Vaccine Data With Keytruda - simplywa...

Assessing Moderna (MRNA) Valuation After Promising Melanoma Vaccine Data With Keytruda  simplywall.st

Moderna Is Curbing Investment in Vaccine Trials Due to US Backlash - Bloomberg

Moderna Is Curbing Investment in Vaccine Trials Due to US Backlash  Bloomberg

Moderna Stock on the Move: What Sparked the 13% Jump in the Past Week? - Yahoo Finance

Moderna Stock on the Move: What Sparked the 13% Jump in the Past Week?  Yahoo Finance

Why Moderna Stock Is Dropping After Good News - Barron's

Why Moderna Stock Is Dropping After Good News  Barron's

Moderna, Merck's skin cancer vaccine shows sustained benefit in five-year follow-up - Reuters

Moderna, Merck's skin cancer vaccine shows sustained benefit in five-year follow-up  Reuters

Moderna (MRNA) Rockets 17% on Strong Preliminary FY25 Results - Yahoo Finance

Moderna (MRNA) Rockets 17% on Strong Preliminary FY25 Results  Yahoo Finance

Why Moderna Stock Surged Today - The Motley Fool

Why Moderna Stock Surged Today  The Motley Fool

Moderna Hits 2025 Revenue Goal as Operating Costs Fall Faster than Forecast - BioSpace

Moderna Hits 2025 Revenue Goal as Operating Costs Fall Faster than Forecast  BioSpace

Moderna (MRNA) stock falls amid market uptick: What investors need to know - MSN

Moderna (MRNA) stock falls amid market uptick: What investors need to know  MSN

Why Moderna (MRNA) Is Up 16.4% After Five-Year Data On Personalized Melanoma mRNA Therapy - Yahoo...

Why Moderna (MRNA) Is Up 16.4% After Five-Year Data On Personalized Melanoma mRNA Therapy  Yahoo Finance

Moderna (MRNA) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Moderna (MRNA) Stock Sinks As Market Gains: Here's Why  Yahoo Finance

Why Moderna Stock Strength Is Only Beginning: Technical Analysis - Barron's

Why Moderna Stock Strength Is Only Beginning: Technical Analysis  Barron's

Moderna (MRNA) Shares Skyrocket, What You Need To Know - Yahoo Finance

Moderna (MRNA) Shares Skyrocket, What You Need To Know  Yahoo Finance

DoD Awards $1.74 Billion Agreement to Moderna, Inc. to Secure Over 65 Million Doses of COV - U.S....

DoD Awards $1.74 Billion Agreement to Moderna, Inc. to Secure Over 65 Million Doses of COV  U.S. Department of War (.gov)

Moderna (NASDAQ:MRNA) Coverage Initiated at Barclays - MarketBeat

Moderna (NASDAQ:MRNA) Coverage Initiated at Barclays  MarketBeat

mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say - Ars Technica

mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say  Ars Technica

Dr. David Berman to Join Moderna as Chief Development Officer - Weatherford Democrat

Dr. David Berman to Join Moderna as Chief Development Officer  Weatherford Democrat

Watch Moderna CEO Says Vaccine Scrutiny Curbing Trials - Bloomberg

Watch Moderna CEO Says Vaccine Scrutiny Curbing Trials  Bloomberg

Recordati Announces Collaboration With Moderna For Mrna-3927 - TradingView

Recordati Announces Collaboration With Moderna For Mrna-3927  TradingView

Moderna secures $1.5B lifeline as it looks to break even in 2028 - BioPharma Dive

Moderna secures $1.5B lifeline as it looks to break even in 2028  BioPharma Dive

Moderna Assures Vaccine De-prioritization in US Doesn't Apply to Cancer - Precision Medicine Online

Moderna Assures Vaccine De-prioritization in US Doesn't Apply to Cancer  Precision Medicine Online

Moderna expands mRNA manufacturing in US at site in Norwood, MA - BioProcess International

Moderna expands mRNA manufacturing in US at site in Norwood, MA  BioProcess International

Moderna, Inc. (MRNA): A Bull Case Theory - Yahoo Finance

Moderna, Inc. (MRNA): A Bull Case Theory  Yahoo Finance

Moderna (MRNA) Partners with Recordati for mRNA-3927 Development and Marketing - GuruFocus

Moderna (MRNA) Partners with Recordati for mRNA-3927 Development and Marketing  GuruFocus

Moderna (MRNA) Leads Healthcare Stocks with Impressive Gains - GuruFocus

Moderna (MRNA) Leads Healthcare Stocks with Impressive Gains  GuruFocus

Moderna, searching for a rebound, to seek approval of mRNA flu shot - BioPharma Dive

Moderna, searching for a rebound, to seek approval of mRNA flu shot  BioPharma Dive

IDWeek 2025: No signal for myocarditis in updated Moderna mRNA COVID vaccine - European AIDS Trea...

IDWeek 2025: No signal for myocarditis in updated Moderna mRNA COVID vaccine  European AIDS Treatment Group

Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more - CNBC

Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more  CNBC

Moderna (MRNA) Valuation Check After Raised 2025 Outlook And Cost Cuts At JPMorgan Conference - Y...

Moderna (MRNA) Valuation Check After Raised 2025 Outlook And Cost Cuts At JPMorgan Conference  Yahoo Finance

IR Insights: Recapping Our Third Quarter 2025 Earnings Report - Moderna

IR Insights: Recapping Our Third Quarter 2025 Earnings Report  Moderna

Moderna and Merck pop on cancer vaccine, Lucid-Rockwell partnership - Yahoo Finance

Moderna and Merck pop on cancer vaccine, Lucid-Rockwell partnership  Yahoo Finance

Moderna's Chief Medical Officer Resigns, New R&D Direction Announced - Intellectia AI

Moderna's Chief Medical Officer Resigns, New R&D Direction Announced  Intellectia AI

Moderna takes on IO Biotech | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Moderna takes on IO Biotech | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

This Stock Is Already Up 58% This Year. Is It a Buy? - Finviz

This Stock Is Already Up 58% This Year. Is It a Buy?  Finviz

Moderna Assures Vaccine Deprioritization in US Doesn't Apply to Cancer - Precision Medicine Online

Moderna Assures Vaccine Deprioritization in US Doesn't Apply to Cancer  Precision Medicine Online

Moderna (MRNA): Reassessing Valuation After a Modest Share Price Rebound - Yahoo Finance

Moderna (MRNA): Reassessing Valuation After a Modest Share Price Rebound  Yahoo Finance

Moderna blueprints $140M plant in bid to bring end-to-end mRNA production to US - Fierce Pharma

Moderna blueprints $140M plant in bid to bring end-to-end mRNA production to US  Fierce Pharma

Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigationa...

Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)  The Batesville Daily Guard

Moderna Recasts Growth Story Toward Oncology As Vaccine Prospects Blur - simplywall.st

Moderna Recasts Growth Story Toward Oncology As Vaccine Prospects Blur  simplywall.st

Moderna (MRNA) Touches 52-Week High on Strong Clinical Results - Yahoo Finance

Moderna (MRNA) Touches 52-Week High on Strong Clinical Results  Yahoo Finance

Jim Cramer on Moderna: “We Have to Wait and See” - Insider Monkey

Jim Cramer on Moderna: “We Have to Wait and See”  Insider Monkey

How Moderna, the company that helped save the world, unraveled - statnews.com

How Moderna, the company that helped save the world, unraveled  statnews.com

Moderna Scores $54 Million From CEPI To Fund Bird Flu Vaccine - BioSpace

Moderna Scores $54 Million From CEPI To Fund Bird Flu Vaccine  BioSpace

Moderna Collaborates With Recordati to Advance, Commercialize Investigational Therapy to Treat Me...

Moderna Collaborates With Recordati to Advance, Commercialize Investigational Therapy to Treat Metabolic Disorder  marketscreener.com

Moderna downsizing investments in late-stage vaccine trials amid U.S. skepticism - CBS News

Moderna downsizing investments in late-stage vaccine trials amid U.S. skepticism  CBS News

Bayer files separate lawsuits against Moderna, J&J and Pfizer-BioNTech over COVID vaccine tech - ...

Bayer files separate lawsuits against Moderna, J&J and Pfizer-BioNTech over COVID vaccine tech  Fierce Pharma

Inside Moderna’s rapid rise — and precarious future - statnews.com

Inside Moderna’s rapid rise — and precarious future  statnews.com

Moderna takes out $1.5B loan, outlines commercial and R&D strategy in bid to break even by 2028 -...

Moderna takes out $1.5B loan, outlines commercial and R&D strategy in bid to break even by 2028  Fierce Pharma

Moderna (MRNA) Is Up 14.8% After Filing Global Applications For Its mRNA Flu Vaccine mRNA-1010 - ...

Moderna (MRNA) Is Up 14.8% After Filing Global Applications For Its mRNA Flu Vaccine mRNA-1010  Yahoo Finance

Trending tickers: AMD, Intel, Moderna, Associated British Foods and Young & Co's Brewery - Yahoo ...

Trending tickers: AMD, Intel, Moderna, Associated British Foods and Young & Co's Brewery  Yahoo Finance UK

Buy or Sell Moderna Stock At $50? - Trefis

Buy or Sell Moderna Stock At $50?  Trefis

Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigationa...

Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)  Corsicana Daily Sun

Moderna signs deal worth up to $503m with Nanexa - Pharmaceutical Technology

Moderna signs deal worth up to $503m with Nanexa  Pharmaceutical Technology

IR Insights: Recapping Our Second Quarter 2025 Earnings Report - Moderna

IR Insights: Recapping Our Second Quarter 2025 Earnings Report  Moderna